The Cortisone Shots Market is experiencing steady growth due to the increasing prevalence of musculoskeletal disorders, arthritis, joint inflammation, and sports-related injuries. Cortisone injections are widely used in clinical practice to help reduce inflammation and relieve pain associated with various orthopedic and inflammatory conditions. Growing demand for minimally invasive treatment options, an aging global population, and advancements in orthopedic and pain management procedures are contributing to market development. In addition, expanding healthcare infrastructure, improved access to specialist care, and increasing awareness of non-surgical treatment approaches are supporting the adoption of cortisone shots across hospitals, specialty clinics, and ambulatory care settings.

Cortisone Shots Market Analysis: The global cortisone shots market was valued at US$ 3.01 billion in 2025 and is expected to reach US$ 4.53 billion by 2034, registering a CAGR of 4.65% during the forecast period 2026–2034. Market growth is supported by increasing demand for treatments that manage inflammation and pain associated with conditions such as osteoarthritis, rheumatoid arthritis, bursitis, and tendinitis. Corticosteroid injections are also used in selected cases to manage symptoms affecting joints, tendons, and other tissues, depending on clinical assessment.

Key Drivers of the Cortisone Shots Market

Increasing Prevalence of Musculoskeletal Disorders

The growing burden of musculoskeletal disorders is an important factor driving the cortisone shots market. Conditions such as osteoarthritis, rheumatoid arthritis, bursitis, and tendinitis can cause persistent pain, inflammation, and reduced mobility. As the prevalence of these conditions increases, demand for effective symptom management options continues to support the use of corticosteroid injections in appropriate clinical settings.

The aging population also contributes to demand, as age-related joint degeneration and osteoarthritis become more common with advancing age. Cortisone shots may be recommended in selected cases to help manage symptoms and support daily functioning.

Download Sample PDF: https://www.theinsightpartners.com/sample/TIPRE00040197

Rising Demand for Non-Surgical Pain Management

Patients and healthcare professionals increasingly consider non-surgical treatment approaches for managing joint pain and inflammation. Depending on the condition, treatment plans may include physical therapy, medication, lifestyle modifications, and corticosteroid injections.

Cortisone shots can provide temporary symptom relief for some patients and may help facilitate participation in rehabilitation programs. This role in conservative treatment pathways supports demand across orthopedic practices, rheumatology clinics, and pain management facilities.

Growth in Orthopedic and Sports Medicine Services

Increasing participation in sports, recreational activities, and fitness programs contributes to demand for orthopedic assessment and injury management. Conditions involving inflamed joints, bursae, and surrounding tissues may require medical treatment, depending on the severity and diagnosis.

The expansion of sports medicine clinics, orthopedic centers, and outpatient services may support access to corticosteroid injections. However, injection suitability varies by injury type, and corticosteroids are not appropriate for every tendon or musculoskeletal condition.

Expansion of Healthcare Infrastructure

Improvements in healthcare infrastructure and access to specialist services are supporting the availability of corticosteroid injections. Hospitals, ambulatory surgical centers, orthopedic clinics, and other outpatient facilities provide settings in which qualified healthcare professionals can evaluate patients and administer injections when appropriate.

The availability of trained practitioners, diagnostic imaging, and follow-up care can influence treatment access and market demand across different regions.

Cortisone Shots Market Trends

Increasing Use of Image-Guided Injections

Ultrasound and other imaging technologies can help healthcare professionals guide injections into specific anatomical locations. Image guidance may improve placement accuracy for selected procedures, particularly when targeting deep joints or structures that are difficult to access using anatomical landmarks alone.

Growing adoption of image-guided procedures is an important trend in orthopedic and pain management services. Its impact on the market depends on equipment availability, clinical protocols, practitioner training, and reimbursement policies.

Growing Focus on Outpatient Treatment

Many corticosteroid injections are administered in outpatient settings, including specialist clinics and ambulatory care facilities. These settings can offer convenient access to assessment and treatment without requiring hospital admission.

The expansion of outpatient orthopedic services and specialized pain management centers may support procedure volumes. Healthcare providers continue to evaluate treatment effectiveness, patient safety, cost, and convenience when determining the appropriate care setting.

Increasing Attention to Treatment Safety

Patient safety and appropriate clinical use are important considerations in the cortisone shots market. Corticosteroid injections may cause temporary discomfort, changes in blood glucose levels, skin changes, or other adverse effects. Repeated injections may carry additional risks, including potential effects on cartilage and nearby tissues, depending on the injection site and frequency.

Healthcare professionals increasingly emphasize individualized treatment plans, appropriate injection intervals, patient counseling, and the evaluation of alternative therapies. These practices influence prescribing decisions and the long-term development of the market.

Advances in Pharmaceutical Formulations

Pharmaceutical manufacturers continue to supply corticosteroid medications in different formulations and strengths for specific clinical applications. Product quality, stability, availability, and compliance with regulatory requirements are important factors in supplier selection.

Market participants may pursue manufacturing improvements, portfolio development, and distribution partnerships to address demand from hospitals, pharmacies, and healthcare providers.

Competitive Landscape of the Cortisone Shots Market

The competitive landscape includes pharmaceutical companies and manufacturers that produce or supply corticosteroid medications and related pharmaceutical products. Competition is influenced by product quality, regulatory approvals, manufacturing capabilities, supply reliability, pricing, and distribution partnerships.

Key companies identified in the market include:

1. Merck & Co., Inc.
2. Pfizer
3. Bristol Myers Squibb Company
4. Novartis AG
5. GlaxoSmithKline
6. Pharmascience Inc.
7. Farmabios S.p.A.
8. AdvaCare Pharma

These companies have differing pharmaceutical portfolios and market exposure. Their involvement in specific corticosteroid injection categories can vary by formulation, indication, geography, and current product portfolio. Their competitive positions may also change through product launches, licensing agreements, manufacturing arrangements, acquisitions, and distribution partnerships.

Future Outlook

This projected growth reflects continued demand for inflammation management, the prevalence of musculoskeletal conditions, and the expansion of orthopedic and outpatient healthcare services.

Future market development will depend on the availability of corticosteroid formulations, advances in injection techniques, clinical guidelines, and access to specialist care. Pharmaceutical manufacturers may find opportunities through product portfolio development, improvements in manufacturing quality, and stronger distribution networks.

At the same time, patient safety, appropriate clinical use, and the availability of alternative treatments will remain important factors influencing the adoption of cortisone shots. Companies that maintain reliable product supply and comply with regulatory standards may be better positioned to serve the evolving needs of healthcare providers.

Related Reports:

Pharmaceutical Excipients Market Growth, Trends & Demand by 2034

Eye Allergy Treatment Market Outlook 2021-2031 | Size, Share and Forecast

About Us

The Insight Partners is a one-stop provider of actionable industry research and intelligence. We help our clients get solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Healthcare IT, Manufacturing and Construction, Medical Devices, Technology, Media and Telecommunications, Food and Beverages, Consumer Goods, and Chemicals and Materials.

Contact US

Contact Person: Ankit Mathur

Phone: +1-646-491-9876

E-mail : sales@theinsightpartners.com